APA (7th ed.) Citation

Gerstein, H. C., Coleman, R. L., Scott, C. A., Xu, S., Tuomilehto, J., Rydén, L., . . . Group, A. S. (2020). Impact of Acarbose on Incident Diabetes and Regression to Normoglycemia in People With Coronary Heart Disease and Impaired Glucose Tolerance: Insights From the ACE Trial. Diabetes Care, 43(9), 2242. https://doi.org/10.2337/dc19-2046

Chicago Style (17th ed.) Citation

Gerstein, Hertzel C., Ruth L. Coleman, Charles A.B Scott, Shishi Xu, Jaakko Tuomilehto, Lars Rydén, Rury R. Holman, and ACE Study Group. "Impact of Acarbose on Incident Diabetes and Regression to Normoglycemia in People With Coronary Heart Disease and Impaired Glucose Tolerance: Insights From the ACE Trial." Diabetes Care 43, no. 9 (2020): 2242. https://doi.org/10.2337/dc19-2046.

MLA (9th ed.) Citation

Gerstein, Hertzel C., et al. "Impact of Acarbose on Incident Diabetes and Regression to Normoglycemia in People With Coronary Heart Disease and Impaired Glucose Tolerance: Insights From the ACE Trial." Diabetes Care, vol. 43, no. 9, 2020, p. 2242, https://doi.org/10.2337/dc19-2046.